HEPH, Pharmadigm licensing deal

Hollis- Eden Pharmaceuticals (HEPH) received exclusive global rights to certain patents from Pharmadigm (Salt Lake City, Utah) and the University of Utah. The patents relate to HEPH's Immune Regulatin...